Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis

References

• Ferro A, Peleteiro B, Malvezzi M, et al. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014;50(7):1330–1344.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;380(9856):1840–1850.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet. 2016;388(10060):2654–2664.
   PubMed Web of Science ®Google Scholar
• Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403–2414.
   PubMed Web of Science ®Google Scholar
• Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149(5):1153–1162.
   PubMed Web of Science ®Google Scholar
• Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–108.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Bhat SA, Ahmad SM, Mumtaz PT, et al. Long non-coding RNAs: mechanism of action and functional utility. Non-Coding RNA Res. 2016;1(1):43–50.
   PubMedGoogle Scholar
• Nasrollahzadeh-Khakiani M, Emadi-Baygi M, Schulz WA, et al. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis. Brief Funct Genomics. 2017;16(3):129–145.
   PubMed Web of Science ®Google Scholar
• Fang XY, Pan HF, Leng RX, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015;356(2):357–366.
   PubMed Web of Science ®Google Scholar
• Gong P, Qiao F, Wu H, et al. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer. Cell Death Dis. 2018;9(12):1158.
   PubMed Web of Science ®Google Scholar
• Zhao J, Du P, Cui P, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene. 2018;37(30):4094–4109.
   PubMed Web of Science ®Google Scholar
• Sun M, Jin F-y, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14(1):319.
   PubMed Web of Science ®Google Scholar
• Shi M, Zhang XY, Yu H, et al. DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma. Oncotarget. 2017;8:44195–44202.
   PubMedGoogle Scholar
• Liu H, Zhang Z, Wu N, et al. Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals functional lncRNAs in gastric cancer. Genes. 2018;9(6):303.
   PubMed Web of Science ®Google Scholar
• Ballantyne M, McDonald R, Baker A. lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016;99(5):494–501.
   PubMed Web of Science ®Google Scholar
• Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015;15(1):38.
   PubMed Web of Science ®Google Scholar
• Cao D, Yu T, Ou X. MiR-873-5P controls gastric cancer progression by targeting hedgehog-GLI signaling. Pharmazie. 2016;71(10):603–606.
   PubMed Web of Science ®Google Scholar
• Yan Y, Fan Q, Wang L, et al. LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells. Oncotarget. 2017;8:35750–35760.
   PubMedGoogle Scholar
• Zhang K, Shi ZM, Chang YN, et al. The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene. 2014;547(1):1–9.
   PubMed Web of Science ®Google Scholar
• Sun M, Nie F, Wang Z, et al. Involvement of lncRNA dysregulation in gastric cancer. Histol Histopathol. 2016;31(1):33–39.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhuang W, Huang M, et al. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma. Biochem Biophys Res Commun. 2019;514(4):1051–1057.
   PubMed Web of Science ®Google Scholar
• Tian J, Cao L, Dong G. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis. Eur Rev Med Pharmacol Sci. 2019;23(13):5714–5729.
   PubMed Web of Science ®Google Scholar
• Chen LL. Linking long noncoding RNA localization and function. Trends Biochem Sci. 2016;41(9):761–772.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
   PubMedGoogle Scholar
• Zhu Y, Zhang X, Qi M, et al. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling. J Gastroenterol Hepatol. 2019;34(12):2126–2134.
   PubMed Web of Science ®Google Scholar
• Jiao D, Guo F, Fu Q. MicroRNA-873 inhibits the progression of thyroid cancer by directly targeting ZEB1. Mol Med Rep. 2019;20(2):1986–1993.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhu W. MicroRNA-873 inhibits the proliferation and invasion of endometrial cancer cells by directly targeting hepatoma-derived growth factor. Exp Ther Med. 2019;18:1291–1298.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang Y, Shi Y, et al. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2. Int J Oncol. 2015;47(4):1603–1611.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Yang H, et al. MicroRNA-873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β-catenin pathway. Int J Oncol. 2019;54(5):1809–1820.
   PubMed Web of Science ®Google Scholar
• Xia T, Liao Q, Jiang X, et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2015;4(1):6088.
   Web of Science ®Google Scholar
• Shelness G, Blobel G. Two subunits of the canine signal peptidase complex are homologous to yeast SEC11 protein. J Biol Chem. 1990;265(16):9512–9519.
   PubMed Web of Science ®Google Scholar
• Shigematsu Y, Oue N, Sekino Y, et al. SEC11A expression is associated with basal-like bladder cancer and predicts patient survival. Pathobiology. 2019;86(4):208–216.
   PubMed Web of Science ®Google Scholar
• Hattori T, Sentani K, Naohide O, et al. Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression. Cancer Sci. 2017;108(1):143–150.
   PubMed Web of Science ®Google Scholar
• Oue N, Naito Y, Hayashi T, et al. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer. Oncogene. 2014;33(30):3918–3926.
   PubMed Web of Science ®Google Scholar